1. Home
  2. CDIO vs GV Comparison

CDIO vs GV Comparison

Compare CDIO & GV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • GV
  • Stock Information
  • Founded
  • CDIO 2017
  • GV 2013
  • Country
  • CDIO United States
  • GV Canada
  • Employees
  • CDIO N/A
  • GV N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • GV Other Consumer Services
  • Sector
  • CDIO Health Care
  • GV Real Estate
  • Exchange
  • CDIO Nasdaq
  • GV Nasdaq
  • Market Cap
  • CDIO 6.4M
  • GV 6.3M
  • IPO Year
  • CDIO N/A
  • GV 2022
  • Fundamental
  • Price
  • CDIO $3.76
  • GV $1.52
  • Analyst Decision
  • CDIO
  • GV
  • Analyst Count
  • CDIO 0
  • GV 0
  • Target Price
  • CDIO N/A
  • GV N/A
  • AVG Volume (30 Days)
  • CDIO 29.6K
  • GV 226.9K
  • Earning Date
  • CDIO 08-14-2025
  • GV 09-19-2025
  • Dividend Yield
  • CDIO N/A
  • GV N/A
  • EPS Growth
  • CDIO N/A
  • GV N/A
  • EPS
  • CDIO N/A
  • GV N/A
  • Revenue
  • CDIO $19,507.00
  • GV $7,773,905.00
  • Revenue This Year
  • CDIO $1,434.82
  • GV N/A
  • Revenue Next Year
  • CDIO $4,661.91
  • GV N/A
  • P/E Ratio
  • CDIO N/A
  • GV N/A
  • Revenue Growth
  • CDIO N/A
  • GV N/A
  • 52 Week Low
  • CDIO $3.22
  • GV $1.00
  • 52 Week High
  • CDIO $53.10
  • GV $9.60
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 47.81
  • GV 42.55
  • Support Level
  • CDIO $3.62
  • GV $1.37
  • Resistance Level
  • CDIO $3.99
  • GV $2.45
  • Average True Range (ATR)
  • CDIO 0.27
  • GV 0.11
  • MACD
  • CDIO 0.03
  • GV -0.03
  • Stochastic Oscillator
  • CDIO 68.00
  • GV 26.32

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

About GV Visionary Education Technology Holdings Group Inc.

Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.

Share on Social Networks: